AMAG Pharmaceuticals, Inc. to Host Conference Call on November 3, 2008 to Discuss Financial Results for the Quarter Ended September 30, 2008.LEXINGTON Lexington. 1 City (1990 pop. 225,366), seat of Fayette co., N central Ky., in the heart of the bluegrass region; inc. 1832, made coextensive with Fayette co. 1974. , Mass. -- AMAG AMAG African Microbicides Advocacy Group AMAG Agricultural Machinery Advisory Group Pharmaceuticals, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AMAG) today announced it will report unaudited consolidated financial results for the quarter ended September 30, 2008 after the U.S. financial markets close on Monday, November 3, 2008. The announcement will be followed by a conference call at 4:30 p.m. ET during which management will discuss the Company's financial results, business highlights and its development programs. To access the conference call via telephone, please dial (877) 412-6083 from the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. or (706) 902-1303 for international access. A telephone replay will be available from approximately 5:30 p.m. ET on November 3, 2008 through midnight November 6, 2008. To access a replay of the conference call, dial (800) 642-1687 from the United States or (706) 645-9291 for international access. The passcode for the live call and replay is 70792779. An audio webcast of the call will be available through the Investors section of the Company's website at www.amagpharma.com. The webcast replay will be available from approximately 7:30 p.m. ET on November 3, 2008 through midnight December 3, 2008. About AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of therapeutic iron compounds to treat anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease . |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion